" class="no-js "lang="en-US"> Jennifer Schneider - Medtech Alert
Wednesday, December 06, 2023
Jennifer Schneider

Jennifer Schneider

About Jennifer Schneider

Before joining Centauri Therapeutics as Chief Executive Officer, Jennifer was Executive Officer, North America for the Global Antibiotic Research & Development Partnership (GARDP). She has nearly twenty years of experience working with companies, universities, and non-governmental organizations in the United States and around the world, providing expertise in antibiotic policy, partnering, and fundraising. She participates in US and international discussions surrounding market creation, access, and novel payment models.

Jennifer received her PhD in molecular biology from the University of Notre Dame and her MPH in epidemiology and international health from the University of Michigan.

Related Story

Centauri Therapeutics Strengthens Senior Leadership Team With Three Key Appointments

July 13 2022

Centauri Therapeutics Limited (Centauri), an immunotherapy company focused on the treatment of infectious diseases, today […]